Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

BACKGROUND: Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. METHODS AND RESULTS: This multicenter retrospe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hocqueloux, Laurent, Choisy, Philippe, Le Moal, Gwenaël, Borsa-Lebas, Françoise, Plainchamp, David, Legac, Eric, Prazuck, Thierry, de la Tribonnière, Xavier, Yazdanpanah, Yazdan, Parienti, Jean-Jacques
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494679/
https://ncbi.nlm.nih.gov/pubmed/23152890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0049289
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller